| Bioelectrical Impedance Vector Analysis in Cirrhotic Patients (NCT01603953) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2009-01-01 |
| Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy (NCT00896831) | Hospital de Clinicas de Porto Alegre | 2008-11-01 |
| A Study of Controlled Lactulose Withdrawal (NCT00914056) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2008-09-01 |
| Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy (NCT00740142) | Mahidol University | 2008-09-01 |
| Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis (NCT01178372) | Govind Ballabh Pant Hospital | 2008-09-01 |
| Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation (NCT00839358) | Hospital Clinic of Barcelona | 2008-08-01 |
| Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy (NCT01097811) | UPECLIN HC FM Botucatu Unesp | 2008-06-01 |
| Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy (NCT00597909) | Amgen | 2007-12-01 |
| Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy Subjects (NCT00931060) | University of Aarhus | 2007-11-01 |
| Rifaximin in Minimal Hepatic Encephalopathy (NCT00533910) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2007-10-01 |
| Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (NCT00558038) | Ocera Therapeutics | 2007-09-01 |
| Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy (NCT00686920) | Bausch Health Americas, Inc. | 2007-03-07 |
| The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure (NCT00655304) | Rigshospitalet, Denmark | 2007-03-01 |
| Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System (NCT00424957) | University of Aarhus | 2006-11-01 |
| A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group (NCT00986895) | Amgen | 2006-09-01 |
| RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial (NCT00364689) | University of Miami | 2006-08-01 |
| Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment. (NCT00305591) | Imperial College London | 2006-03-01 |
| A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy (NCT00298038) | Bausch Health Americas, Inc. | 2005-12-19 |
| Neuromonitoring of Hepatic Encephalopathy (NCT01878305) | University of Helsinki | 2005-12-01 |
| Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life (NCT00375375) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2004-01-01 |
| Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy (NCT00433368) | Aga Khan University | 2003-10-01 |
| Manganese in Women With Encephalopathy (NCT00985010) | Materno-Perinatal Hospital of the State of Mexico | 2003-01-01 |
| Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy (NCT00955500) | Hospital Universitari Vall d'Hebron Research Institute | 2003-01-01 |
| Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy (NCT01223742) | University of Catania | 2002-06-01 |
| Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) (NCT00287235) | Vantive Health LLC | 2000-09-01 |
| A Multi-Center Group to Study Acute Liver Failure in Children (NCT00986648) | University of Pittsburgh | 2000-01-01 |
| Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis (NCT00004796) | National Center for Research Resources (NCRR) | 1994-11-01 |